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Abstract
A cardiovascular system (CVS) model has previously been validated in sim-
ulated cardiac and circulatory disease states. It has also been shown to accu-
rately capture all main hemodynamic trends in a porcine model of pulmonary
embolism. In this research, a slightly extended CVS model and parameter
identification process are presented and validated in a porcine experiment of
positive end-expiratory pressure (PEEP) titrations at different volemic levels.
The model is extended to more physiologically represent the separation of
venous and arterial circulation. Errors for the identified model are within 5%
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when re-simulated and compared to clinical data. All identified parameter
trends match clinically expected changes. This work represents another clin-
ical validation of the underlying fundamental CVS model, and the methods
and approach of using them for cardiovascular diagnosis in critical care.
Keywords: cardiovascular system, cardiac model, parameter identification,
integral method, PEEP, hypovolemia
1 Introduction
Cardiac disease state is highly patient specific and difficult to accurately
diagnose due to the limited measurements typically available. Therefore,
successful diagnosis and treatment often rely on the experience and intuition
of clinical staff. A physiologically validated computer model could offer sev-
eral advantages in diagnosis and therapy guidance, by aggregating diverse
and less transparent patient data into an overall patient-specific, clinically
relevant assessment of a patient’s circulatory status.
In particular, a CVS model can be formulated in terms of equations whose
parameters are physiologically relevant. When patient-specific parameters
can be identified from measured clinical data so that the model matches the
clinical measurements, a patient-specific model of their fundamental dynamic
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(Pressure-Volume, PV) behavior is created. These physiologically relevant
parameters can then be used to assist clinical staff with diagnosis.
For example, the contractility index of the left ventricle can be elevated
or depressed, thus giving insight into the performance of the ventricle. A
similar example would be the parameter representing the pulmonary vascu-
lar resistance providing information about the pressures in the pulmonary
arteries, to ascertain if an embolus is developing. More complex examples
could include discerning the onset of septic or other forms of shock [1].
Therefore, by observing how patient-specific parameters change over time
(new identifications can be performed for any few heartbeats of data) valu-
able information about the patient’s hemodynamic condition can be tracked,
diagnosed and monitored to help provide effective treatment. This use of
the model has already been validated on clinical data from animal trials
(pigs) in induced pulmonary embolism [2]. This research presents a further
validation of the model and methods by identifying the different hemody-
namic conditions that result from changing PEEP and volemic levels, which
are common therapies in critical care that can have significant impact on
circulatory function.
Spontaneous breathing and ventilation can have extensive effects on car-
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diovascular function. These effects are usually well tolerated in healthy sub-
jects but may cause detrimental hemodynamic effects in critically ill patients,
where pulmonary and or cardiovascular diseases and dysfunctions are present.
It is thus important to understand the cardiopulmonary interactions and ac-
count for them when modelling the cardiovascular system.
Positive end-expiratory pressure (PEEP) is an operator-controlled vari-
able that can be set during mechanical ventilation. The correct value of
PEEP can be beneficial or detrimental for the patient dependent on how it
is used. More specifically, in patients with lung injury, high PEEP levels
may be necessary to maintain or restore oxygenation and for each individual
patient the right balance between too much and too little PEEP has to be
found. Too little PEEP may result in airway or alveolar collapse, whereas too
much PEEP can cause alveolar overdistention and hemodynamic problems
such as a reduction in cardiac output (CO).
In this research, the CVS model is extended to more realistically capture
different hemodynamic conditions resulting from the application of different
PEEP values and levels of normo-, hypo- and hypervolemia. Compared to
prior work, the minimal data required for the parameter identification process
has been further reduced. The whole approach is thus more applicable for a
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clinical environment despite a modest model extension. In particular, instead
of using the left and right ventricular systolic and diastolic volumes, only the
global end-diastolic volume (GEDV) and an estimated total blood volume
(TBV) are now needed to identify the different PEEP and volemic levels
correctly. The identification process has also been modified from prior work
to allow for a more robust identification.
2 Methodology
2.1 CVS model
The CVS model is a simple, yet clinically validated model for the heart and
circulation [3]. This model comprises a series of connected pressure-volume
chambers with greater detail for the active ventricular portions of the heart
and their interaction. More specifically, the left/right ventricle, aorta, pul-
monary artery/vein, vena cava are captured as explicit physiological regions
with independent fundamental circulatory (PV) dynamics. A more detailed
description of this foundation CVS model can be found in [2–4].
In this research, the original CVS model has been extended to include
one extra compartment for the lung capillaries. A second has been added
for the body capillaries, thus separating the venous and arterial systems and
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resistances. Figure 1 shows these changes with the two new compartments
P, Vsys and P, Vcap which represent the systemic and pulmonary capillaries,
respectively. However, for reasons of simplicity and avoiding unnecessary
complexity, only 1 additional compartment was added for the pulmonary
and systemic circulation, respectively.
This physiological addition is of great interest for heart-lung interactions
during positive pressure ventilation (PPV), particularly when studying the
effect of different PEEP levels. When PEEP is raised, increases in intratho-
racic pressure (Pth) cause right ventricular preload to decrease by increasing
the resistance to venous return (Rvr), and left ventricular afterload to de-
crease [5, 6]. This afterload reduction is achieved by a decrease in systemic
resistance (Rsys). One can see, that two resistances on either side, the ar-
terial and venous side, are necessary to correctly simulate these complex
behaviors observed clinically during mechanical or spontaneous breathing,
thus physiologically justifying this model extension.
2.2 Integral-Based Parameter Identification
The parameter identification method used in this research has previously
been shown to rapidly and accurately identify almost the entire parameter
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set in the presence of significant measurement noise [2, 7]. This identifica-
tion method is modified in this research to allow a more robust parameter
identification with similar or lesser data requirements.
2.2.1 Adjustments to arterial elastances (Eao, Epa)
The main modifications to previous work include keeping the arterial elas-
tances (Eao, Epa) fixed, thus allowing other parameters to be more easily and
accurately calculated. Arterial compliance is defined as the change in volume
following a change in pressure. Arterial elastance is given as the reciprocal
of the compliance and thus by a pressure change (4P ) following a volume
change (4V ). Many researchers have concluded, that arterial elastance can
consequently be calculated by substituting the pulse pressure (PP) for 4P
and stroke volume (SV) for 4V as given by following equations [8, 9]:
Eao =
PPao
SV
(1)
Epa =
PPpa
SV
(2)
Hence, Eao and Epa are no longer identified, but are directly obtained from
the measured arterial and pulmonary artery pulse pressures (PPao, PPpa)
and stroke volumes. If Ppa is not measured, Eao is still known as it can be
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assumed that Pao and SV are almost always measured in acute critical care
patients. Note that, in this research, Equations 1 and 2 are adjusted by a
multiplying factor of 1.25 to account for dynamic effects in static measures,
as it was found from observing the relationship between SV and Vao/Vpa,
that adding this factor improves the estimate for Eao and Epa. Otherwise
both elastances would be slightly underestimated. Consequently, the two
parameters, systemic vascular resistance and elastance (Rsys, Esys) can thus
be determined directly using:
Rsys =
Eao · (
∫
Psys −
∫
Pao)
(Pao − Pao0 −
∫
Qav · Eao) (3)
Esys =
∫
Pao −Rsys · (
∫
Qav − 1/Eao · (Pao − Pao0))∫
Vsys
(4)
where the integral is taken from measured data (numerically). Similarly,
pulmonary vascular resistance and elastance (Rpulin and Ecap) can also be
found:
Rpulin =
Epa · (
∫
Pcap −
∫
Ppa)
(Ppa − Ppa0 −
∫
Qpv · Epa) (5)
Ecap =
∫
Ppa −Rpulin · (
∫
Qpv − 1/Epa · (Ppa − Ppa0))∫
Vcap
(6)
Note that for reasons of clarity, the differential dt, and upper and lower limits
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of integration are omitted. If not stated otherwise, the integration is done
over at least one heart beat. In cases where matrices are constructed sepa-
rately for ejection and filling periods, the integrals are only calculated during
these periods. More detailed information about this part of the identification
process can be found in [2, 7].
2.2.2 Scaling process
Where the waveforms are not known and only discrete measurements are
available the integral method of [7] cannot be directly applied. However,
waveforms can be artificially generated by scaling a set of previously calcu-
lated model outputs to best fit the discrete maximum and minimum mea-
sured data values over one or more heart beats for the pressures and volumes.
The assumption is that these validated model waveforms are reasonably con-
formable with the actual clinical case.
These scaled signals are then re-identified and a new CVS forward simula-
tion is performed with the previously identified parameters producing a much
closer match to the clinical data than the first initial, assumed parameter set.
The simulated output is then compared to the clinical data. Subsequently,
the output signals are re-scaled and new parameters are identified that are
then again used to run another simulation. This iterative process is stopped
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when the relative error between model output and clinical data reaches a set
tolerance.
2.2.3 Substitution of flow integrals during the scaling process
Another modification to the methods of [2, 7] has been made to better cal-
culate the parameters that are determined by the flows in and out of the
ventricles. Previously, these flows have been used in the identification pro-
cess. This approach introduced significant error during the scaling process,
where only the pressure and volume signals, but not the unknown associated
flows, are scaled. To address this issue, the flow integrals
∫
Qmt,
∫
Qav,
∫
Qtc
and
∫
Qpv are now substituted by their corresponding volumes, as given in
Equations 7 - 10.
Vlv(ef)− Vlv(eb) = −
∫ ef
eb
Qav dt (7)
Vlv(ff)− Vlv(fb) =
∫ ff
fb
Qmt dt (8)
Vrv(ef2)− Vrv(eb2) = −
∫ ef2
eb2
Qpv dt (9)
Vrv(ff2)− Vrv(fb2) =
∫ ff2
fb2
Qtc dt (10)
with eb,eb2=ejection begin for LV,RV; ef ,ef2=ejection finish for LV,RV;
fb,fb2= filling begin for LV,RV and ff ,ff2=filling finish for LV,RV. This
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approach has the advantage that the volumes in the ventricles are either
measured or estimated signals, whereas the flows are usually not measured
or estimated. Hence, significantly less error is introduced during the scaling
part of the parameter identification process using these discrete measure-
ments. Figure 2 shows in the upper panel the flow integral and corresponding
volume signal for Qav. The lower panel shows the difference between both
signals which is negligible.
2.3 Volume Calculations
The parameter identification process needs the two ventricle volumes as input
signals to accurately determine some of the parameters. More specifically,
the end-diastolic and end-systolic volumes (EDV, ESV) are needed. However,
these volume measurements are usually not available in a clinical environment
and thus need to be estimated from the clinically available data.
Currently, the LVEDV and RVEDV are estimated based on an estimated
total blood volume (TBV) and the measured global end-diastolic volume
(GEDV). As the stroke volume (SV) is also a measured variable, ESV can be
calculated by subtracting SV from EDV. The total blood volume is estimated
as 85 ml/kg, with 25ml/kg being stressed volume and 60ml/kg unstressed
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volume based on clinical results [10].
GEDV is the end-diastolic volume of the left and right ventricle and
the two atria. Comparing the given GEDV measurements for the pigs in
this study with typical porcine ventricular volume measurements from other
studies [2, 11–13], it can be seen that GEDV seems to be slightly overesti-
mated here. Hence, the GEDV used in this research is corrected by a factor
f = 2/3 to produce commonly seen LVEDV and RVEDV values for healthy
pigs based on their weight. Furthermore, from these studies it can also be
assumed that the right ventricle usually contains more blood than the left
ventricle, especially in the case where a high PEEP value is present [14].
This estimation is further validated by several studies using angiography to
measure the ventricle volumes and it has been demonstrated that the normal
left-ventricular end-diastolic index (LVEDVI) in man is 70 to 80 mL/m2,
whereas the mean right-ventricular end-diastolic volume index (RVEDVI) is
80 to 85 mL/m2 [15–17]. Additionally, it can be estimated that within the
heart, blood is distributed with 60% in the ventricle and 40% in the atrium
[18]. Hence the LVEDV and RVEDV are estimated by following equations:
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LV EDV = 2/3 ·GEDV · 0.6 · 0.4 (11)
RV EDV = 2/3 ·GEDV · 0.6 · 0.6 (12)
The remaining model volumes can be estimated based on known blood distri-
butions. Importantly, the volume in the pulmonary capillary and vein com-
partments (Vcap, Vpv) make up the entire pulmonary blood volume (PBV),
which can be estimated as GEDV/4 [19]. The volumes in the aorta and
pulmonary artery are directly obtained from the measured pressures Pao and
Ppa and the calculated elastances Eao and Epa. These two volumes are thus
defined by the simple definition:
V =
P
E
(13)
Note that for simplicity, the unstressed volumes are omitted, except for the
systemic and pulmonary volume compartments (Vsys, Vcap), which both are
modelled using stressed and unstressed volumes. Further, as a result of these
estimations, specific detailed questions cannot be answered, as information
is lost on how one ventricle expands relative to the other. For example, the
RVEDV/LVEDV expansion index is no longer valid due to these assump-
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tions. However, this research focuses on identifying the change in SV, which
is directly given as a measured signal, rather than identifying specific ven-
tricular volumes or related dysfunction. Thus, this identification method is
specific to capturing these circulatory effects due to changes in PEEP, which
is a relatively common occurrence in the ventilated critical care patient.
2.4 Summary of the identification process
Figure 3 gives an overview of the identification process, which is based on
previous work [2, 7]. Modifications to the overall process are described above.
The following steps are performed:
1. Obtain clinical measurements and signals as shown in Table 1
2. Use volume calculations to estimate the initial volume conditions for
the CVS model
3. Use initial set of parameters to obtain first simulation output [2]
4. Scale simulation output signals (Ppa, Pao, Vlv, Vrv) to match the clinical,
porcine data [2]
5. Identify the animal-specific parameters for the scaled signals using the
integral-based methods based on [7]
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6. Re-scale the simulation output signals to better match the porcine data
7. Repeat steps 4 to 6
8. Stop the iterative process when a set error tolerance is reached
2.5 PEEP experiment study protocol
2.5.1 Instrumentation and Monitoring
The experiment was approved by the Danish National animal ethics commit-
tee and data of seven 20-22kg pigs was analyzed for this research. A detailed
description of the anesthesia, ventilation, instrumentation and monitoring
procedure has been published in [20]. Thus, only a brief discussion of the
study protocol where it is relevant for this analysis is provided here.
Measurements were obtained from the right femoral artery, right carotid
artery and the right internal jugular vein for monitoring the intravascular
pressures and cardiac output. Pulmonary artery pressure was recorded us-
ing a PAC (Swan-Ganz, CCO mbo CCO/SvO2 7.5F, Edwards Lifesciences,
Irvine, CA) and esophageal pressure was measured via a latex ballon catheter
(Viasys Healthcare, Hochberg, Germany). The esophageal catheters were
connected to transducers (T450545A, Edwards Lifesciences, Irvine, CA) and
the signals were transferred to a monitor (CM4008, Cardiomed, Ontario,
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Canada). Data were continuously measured and stored on a computer using
Matlab (The MathWorks, MA). Analysis was performed using Matlab. Table
1 gives an overview of the measurements and signals used for the pig-specific
parameter identification.
2.5.2 Interventions
The measurements were performed at three different PEEP levels of 0, 10
and 20cmH2O and at 5 different volemic levels: baseline (normovolemia, N),
10% volume loss (hypovolemia, H), re-transfusion of blood (normovolemia,
I1), infusion of a volume equal to 10% of the estimated blood volume (10%
hypervolemia, I2) and infusion of a volume equal to 20% of the estimated
blood volume (20% hypervolemia, I2). Each blood infusion or removal was
done over a period of 5 minutes, followed by a 10 minute stabilization period
with 5cmH2O PEEP to guarantee steady-state measurements.
3 Results
3.1 PEEP titration experiment at different volemic
levels
The integral-based parameter identification is applied to clinical porcine data
for clinical model validation. Detailed results for three of the seven pigs are
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presented and a summary of all seven pigs is given in Table 2. Figure 4
shows in the upper panel of the Pressures panel the simulated model output
for the systolic and diastolic pressures in the aorta (SAP and DAP, solid
line). The circles are the measured systolic and diastolic pressures. Note,
that the x-axis shows the interventions performed during the PEEP titration
protocol, where the 0−20 range represent the beginning of a PEEP sequence
of 0, 10 and 20cmH2O. The symbols N, H, I1, I2 and I3 stand for baseline
normovolemia (N), hypovolemia (H), re-transfusion normovolemia (I1), 10%-
and 20% hypervolemia (I2 and I3), respectively. The middle panel shows the
systolic and diastolic pulmonary artery pressures (SPAP and DPAP) and the
lower panel shows the central venous pressure (CVP). The simulation data
match the measured porcine data well with absolute errors well below 5% for
the maximum and minimum pressures.
Figure 4 displays in the upper panel of the Volumes panel the measured
GEDV (one measurment/circle per intervention) and the simulated ventricu-
lar end-diastolic volume VEDV (VEDV=LVEDV+RVEDV, upper solid line).
Note that the plotted GEDV is the corrected GEDV that has been multi-
plied with a correction factor of 2/3. In addition, as the atria volumes are
not included in this model, VEDV is multiplied by a factor of 1.6 (160% of
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VEDV equals GEDV) to enable a direct comparison between the two vol-
umes. The second line in the upper panel represents measured PBV (one
measurment/circle per intervention) and the solid line represents the simu-
lated pulmonary venous and capillary blood volume. Finally, the lower panel
shows the measured (circles) and simulated SV (solid line). In all cases, the
simulation data match the measured porcine data well with absolute errors
well below 10% for the maximum and minimum volumes.
Figure 5 shows the simulated vs clinally measured pressure and volume
signals for pig #3 and Figure 6 shows the same results for pig #5. Similar
trends and good results are seen for all other pigs, as can also be seen in
Table 2.
Figure 7 clearly shows that the identified subject (pig) specific parame-
ters for the venous return resistance (Rvr) and pulmonary vascular resistance
(Rpulin), differ significantly between the PEEP=0cmH2O and PEEP=20cmH2O
states. For all seven pigs, Rvr increases when PEEP is applied. This increase
is particularly significant during the hypo- and normo-volemia (H, N and I1)
cases. Less significant changes are observed during hypervolemia (I2 and I3).
Likewise, Rpulin increases with increasing levels of PEEP with similar trends.
Figure 8 shows how Rvr directly correlates with Psys/SV for all 96 iden-
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tified segments and similar good correlations are obtained for the systemic
vascular resistance (Rsys) and (SAP−Psys)/SV , and for Rpulin and (SPAP−
Pcap)/SV , respectively. In all three cases, the correlations are tight (r=0.8-
0.99) with few outliers, indicating clear correlation, as expected.
Finally, Figure 9 shows the correlations for the ventricle contractilities
Eeslvf , Eesrvf and the ratio of systolic arterial pressure and end-systolic vol-
ume. Very tight correlations are obtained in both of these cases, as well.
4 Discussion
Mechanical ventilation, for example PPV with additional PEEP, can cause
profound steady-state hemodynamic effects in critically ill patients. As respiratory-
induced changes in Pth are transmitted directly to all vessels in the thoracic
cavity, the pressure in the right atrium increases during PPV. It is also known
that PEEP often reduces venous return (VR) and thus cardiac output (CO)
[5, 6, 21].
Over the years there has been some controversy how exactly PEEP alters
VR. Some investigators have concluded that PEEP decreases VR by reducing
the pressure gradient (Psys − Pra) [22]. Note, that Psys is the mean systemic
pressure, which is also known as mean circulatory filling pressure (MCFP).
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Since this CVS model does not explicitly model the right atrium, but lumps it
together with the vena cava, Pra is represented in this model by Pvc. However,
other researchers have demonstrated that Psys and Pra change equally during
positive airway pressure and thus a change in the driving pressure gradient
cannot be the reason for decreases in VR during PEEP [5, 23, 24]. Recent
publications suggest that the main effect by which PEEP decreases venous
return is by increasing the resistance to venous return [5, 6, 21].
Thus, during PEEP, VR is decreased not by altering the pressure gradient
(Psys − Pra), but by increasing the resistance to venous return, modelled
here as Rvr. Hence, different PEEP levels should result in different values
for Rvr. More specifically, Rvr should increase during elevated PEEP levels,
which is shown in Figure 7 and matches physiological expectations [5, 23, 24].
Furthermore, it is also known that right ventricular afterload increases during
PPV [6], so one would expect Rpulin to also increase with increasing levels of
PEEP. Figure 7 shows this result, as expected.
Additionally, reflex response mechanisms of the body act to decrease un-
stressed systemic volume (Vdsys) and thus increase the stressed systemic vol-
ume (Vsys), which in turn leads to a rise in Psys and helps to sustain the
pressure gradient for VR [25, 26]. The CVS model and identification method
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successfully capture this behavior, as can be seen in Figure 10. Figure 10 dis-
plays, how the effective systemic volume Vsyseff (with Vsyseff = Vsys− Vdsys)
rises with PEEP levels from 0 to 20cmH2O. Figure 10 shows the systemic vol-
ume Vsys normalized by the baseline value for PEEP 0cmH2O. The increase
in Vsys is more accentuated during hypo-(H) and normo(N,I1)-volemia, which
is expected because the central venous pressure and intrathoracic pressure
are both higher during these states compared to the 10%- and 20% hyper-
volemia (I2,I3). Note, that PBV also decreases with rising PEEP levels, as
the volume is shifted from the pulmonary circulation centrally to help raise
Vsys [25] as seen in the volume panels of Figures 4 - 6.
In the pressure panels of Figures 4 - 6 it can be seen how well the increase
in CVP is matched by simulated data from the CVS model for the different
PEEP levels. Furthermore, Figure 8 shows that Rvr correlates directly with
the ratio of Psys and stroke volume, which is expected as the pressure gradi-
ent (Psys − Pvc) divided by SV approximates the mean resistance to venous
return. Note, that as the pressure gradient remains relatively equal and both
pressures change similarly, it does not matter if (Psys−Pvc)/SV or Psys/SV
is calculated.
Similar good correlations for Rsys and Rpulin are obtained as shown in
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Figure 8. These correlations further validate the CVS model and identi-
fication method as the identified parameters behave as expected based on
physiological observations. Similarly, good correlations for the two ventricle
contractilities (Eeslvf , Eesrvf ) are given in Figure 9, and are also expected
physiologically. In this model, Vd (ESPVR and x-axis intercept) is set to
zero for simplicity. Thus, one can see that ESPVR is approximated by the
ratio of systolic arterial pressure to end-systolic volume (SAP/ESV).
Finally, Table 2 summarizes all the results for all seven pigs over a total
of 96 separate identification cases. Note, that 9 measurements had to be
omitted from the final analysis as they contained corrupted data, such as
those produced by disconnected catheters. These summary results show that
the minimal CVS model is able to capture the essential dynamics of the
porcine CVS response to increasing levels of PEEP over a variety of volemic
conditions and over a selection of subjects. The minimal errors and strong
correlations seen in this table and other figures indicate that the parameters
are also behaving physiologically and not merely matching the data.
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5 Conclusion
The extended CVS model has successfully been shown to accurately simulate
the impact different PEEP and volemic levels have on the hemodynamic
status of the pigs. More specifically, separating the arterial and venous sides
of both, systemic and pulmonary, circulation improved the model accuracy
in simulating mechanical ventilation, where a reduction in LV afterload can
be present along with a reduction in RV preload, thus requiring a reduction
in Rsys, however a simultaneous increase in Rvr. This would not have been
possible in the previous CVS model.
The integral-based optimization successively identified pig-specific pa-
rameters for the minimal cardiac model for a series of PEEP and volemic
interventions. This validation study shows the ability of the model to ade-
quately and realistically capture (with unique values) the impact of pressure-
volume changes with PEEP and fluid therapy. The study cohort of seven
porcine experiments may not be sufficient to truly validate the model and
methods and further experiments are planned. However, while a full clinical
validation of the model and further evaluation of the system are required,
the model shows great potential and increases the confidence in the clinical
applicability and validity of the developed methods and their use in clinical
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diagnostic monitoring.
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Figure 1: Extended CVS model overview which includes additional compart-
ments P, Vsys and P, Vcap to differentiate the arterial and venous sides of the
pulmonary and systemic circulation.
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Figure 2: Substitution of flow signal with volume signal during identification
process (upper panel) and difference between these two signals (lower panel).
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Figure 3: Parameter identification algorithm: 1.) a set of parameters is used
for an initial simulation, 2.) data are then scaled to match the measured
data and 3.) identified. This process is iterated until the simulation output
is acceptable.
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Measurements used for parameter ID
Signal Obtained from Comments
stoke volume PiCCO monitor
(SV) (Pusion Medical Systems,
Munich, Germany)
arterial pressure PiCCO monitor systolic and diastolic values
(APsys, APdia)
pulmonary artery pressure SC9000 monitor systolic and diastolic values
(PAPmax, PAPmin) (Siemens Medical Systems,
Germany)
central venous pressure SC9000 monitor mean value
(CVPmean)
heart rate PiCCO monitor
global end-diastolic volume PiCCO monitor corrected by 2/3
(GEDV)
pulmonary blood volume PiCCO monitor
(PBV) estimated as GEDV/4
esophageal pressure CM4008 monitor mean value
(Pesomean) (Cardiomed, Ontario,
Canada)
Table 1: Signals that are used in the identification process to obtain the
pig-specific parameters and to match the output signals of the CVS forward
simulations to.
Difference in % for measured and simulated pressures and volumes
SAP DAP SPAP DPAP CVP SV
µ 3.57 5.51 3.79 4.98 3.55 5.35
σ 2.22 3.34 2.36 3.35 2.36 3.38
Table 2: Mean error and standard deviation in % for measured and simulated
pressures and volumes over all 96 identified segments. SAP = systolic arterial
pressure, DAP = diastolic arterial pressure, SPAP = systolic pulmonary
artery pressure, DPAP = diastolic pulmonary artery pressure, CVP = central
venous pressure, SV = stroke volume.
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Figure 4: Pig 1, Model output (solid lines) vs clinical (circles) data for pres-
sures and volumes. For the pressures, the upper panel shows systolic and
diastolic arterial pressures (SAP, DAP), the middle panel shows systolic and
diastolic pulmonary artery pressures (SPAP, DPAP) and the lower panel
shows the central venous pressure (CVP). For the volumes, the upper panel
shows the GEDV and PBV and the lower panel shows the stroke volume
(SV).
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Figure 5: Pig 3, Model output (solid lines) vs clinical (circles) data for pres-
sures and volumes. For the pressures, the upper panel shows systolic and
diastolic arterial pressures (SAP, DAP), the middle panel shows systolic and
diastolic pulmonary artery pressures (SPAP, DPAP) and the lower panel
shows the central venous pressure (CVP). For the volumes, the upper panel
shows the GEDV and PBV and the lower panel shows the stroke volume
(SV).
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Figure 6: Pig 5, Model output (solid lines) vs clinical (circles) data for pres-
sures and volumes. For the pressures, the upper panel shows systolic and
diastolic arterial pressures (SAP, DAP), the middle panel shows systolic and
diastolic pulmonary artery pressures (SPAP, DPAP) and the lower panel
shows the central venous pressure (CVP). For the volumes, the upper panel
shows the GEDV and PBV and the lower panel shows the stroke volume
(SV).
35
N−0 N−20 H−0 H−20 I1−0 I1−20 I2−0 I2−20 I3−0 I3−20
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
interventions
R
vr
(a) Rvr
N−0 N−20 H−0 H−20 I1−0 I1−20 I2−0 I2−20 I3−0 I3−20
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
interventions
R
pu
l in
(b) Rpulin
Figure 7: Identified Rvr and Rpulin values for all 7 pigs and all PEEP/volume
interventions.
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Figure 8: Correlation for all 96 identified segments for all 7 pigs and all
PEEP/volume interventions.
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Figure 9: Correlation for SAP/LV ESV vs Eeslvf and SPAP/RV ESV vs
Eesrvf for all 96 identified segments for all 7 pigs and all PEEP/volume
interventions.
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Figure 10: Effective normalized systemic volume for all 15 identified segments
for pigs 1,3 and 5 over all PEEP/volume interventions.
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